SCHEMBL8093993

SCHEMBL8093993

CCCCOc1nc(-c2cccc(OC)c2)c(-c2ccc(S(N)(=O)=O)cc2)cc1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.47
CA9 Q16790 9/20 0.45
CA2 P00918 8/20 0.45
CA1 P00915 7/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
LDHA P00338 2/20 0.43
LDHB P07195 2/20 0.43
CA12 O43570 4/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
CDK2 P24941 2/20 0.42
TSHR P16473 1/20 0.41
CA7 P43166 1/20 0.41
TTK P33981 2/20 0.41
MAPK8 P45983 1/20 0.41
CDK1 P06493 1/20 0.40
CNR2 P34972 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086926 0.92 PTGS2 (0.52) CNR1PTGS1PTGS2MAPK8CNR2
SCHEMBL8086798 0.89 PTGS2 (0.44) CNR1CA9CA2CA1CA5A
SCHEMBL8094646 0.88 PTGS2 (0.42) CNR1CA9CA2CA1CA12
SCHEMBL8095681 0.86 CA2 (0.51) CNR1CA9CA2CA1CA12
SCHEMBL8094362 0.85 PTGS2 (0.59) CA9CA2CA1CA4CA5A
SCHEMBL8087099 0.85 PTGS2 (0.48) CNR1CA9CA2CA1CA12
SCHEMBL8092716 0.85 PTGS2 (0.51) CNR1PTGS1PTGS2CDK2
SCHEMBL8092693 0.85 PTGS2 (0.50) CNR1PTGS1PTGS2CNR2
SCHEMBL8094547 0.84 PTGS2 (0.60) CNR1CA9CA2CA1CA12
SCHEMBL8098696 0.83 PTGS2 (0.47) CNR1CA9CA2CA1CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP claimed
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed